Enterovirus/Picornavirus infections

Handbook of Clinical Neurology

Volumn 123, Issue , 2014, Pages 379-416

  Jubelt, Burk ^a   Lipton, Howard L ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Acute cerebella ataxia; Aseptic meningitis; Brainstem encephalitis; Cerebrospinal Fluid; Chronic infections; Conjunctivitis; Coxsackieviruses; Cranial nerve palsies; Echoviruses; Encephalitis; Enteroviruses; Hand foot and mouth disease; Herpangina; Hygiene; Myocarditis Pericarditis; Nucleic acid amplification; Paralytic disease; Pleurodynia; Polioviruses; PV Vaccination; Rashes; Rhombencephalitis

Indexed keywords

ACUTE CEREBELLA ATAXIA; ARTICLE; ASEPTIC MENINGITIS; BORNHOLM DISEASE; BRAINSTEM ENCEPHALITIS; CEREBROSPINAL FLUID; CHRONIC INFECTIONS; CONJUNCTIVITIS; COXSACKIE VIRUS; CRANIAL NERVE PALSIES; ECHO VIRUS; ENCEPHALITIS; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENETICS; HAND-FOOT-AND-MOUTH DISEASE; HERPANGINA; HISTORY; HUMAN; HYGIENE; MYOCARDITIS/PERICARDITIS; NEUROLOGIC DISEASE; NUCLEIC ACID AMPLIFICATION; PARALYSIS; PATHOGENICITY; POLIOMYELITIS VIRUS; PV VACCINATION; RASHES; RHOMBENCEPHALITIS; ULTRASTRUCTURE; VIROLOGY;

ACUTE CEREBELLA ATAXIA; ASEPTIC MENINGITIS; BRAINSTEM ENCEPHALITIS; CEREBROSPINAL FLUID; CHRONIC INFECTIONS; CONJUNCTIVITIS; COXSACKIEVIRUSES; CRANIAL NERVE PALSIES; ECHOVIRUSES; ENCEPHALITIS; ENTEROVIRUSES; HAND-FOOT-AND-MOUTH DISEASE; HERPANGINA; HYGIENE; MYOCARDITIS/PERICARDITIS; NUCLEIC ACID AMPLIFICATION; PARALYTIC DISEASE; PLEURODYNIA; POLIOVIRUSES; PV VACCINATION; RASHES; RHOMBENCEPHALITIS;

ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84903975415     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53488-0.00018-3     Document Type: Chapter

References (442)

1. Abed Y., Boivin G. New Saffold cardiovirus in 3 children in Canada. Emerg Infect Dis 2008, 14:834-836.
2. Acharya V.Z., Talwar D., Elliott S.P. Enteroviral encephalitis leading to a locked-in state. J Child Neurol 2001, 16:864-866.
3. Agol V.I., Drozdov S.G., Frolova M.P., et al. Neurovirulence of the intertypic poliovirus recombinant v3/a1-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome. J Gen Virol 1985, 66:309-316.
4. Alexander J.P., Chapman L.E., Pallansch M.A., et al. Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis 1993, 167:1201-1205.
5. Alexander J.P., Ehresmann K., Seward J., et al. Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis 2009, 199:391-397.
6. Anderson G.W., Rondeau S.L. Absence of tonsils as a factor in the development of bulbar poliomyelitis. JAMA 1954, 155:1123-1130.
7. Archimbaud C., Chambon M., Bailly J.L., et al. Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol 2009, 81:42-48.
8. Armstrong C. Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Public Health Rep 1939, 54:2302-2305.
9. Artenstein M.S., Caoigan F.C., Beuscher E.L. Epidemic coxsackievirus infection with mixed clinical manifestations. Ann Intern Med 1964, 60:196-203.
10. Arya S.C. The behavior of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys. J Biol Stand 1977, 5:275-281.
11. Asbury A.K. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981, 9(Suppl):1-5.
12. Asherson G.L., Webster A.D.B. Sex-linked hypogammaglobuJinaemia. Diagnosis and treatment of immunodeficiency diseases 1980, 7-36. Blackwell, Oxford. G.L. Asherson, A.D.B. Webster (Eds.).
13. Ashkenazi A., Melnick J.L. Heterotypic antibody response after feeding of monovalent attenuated live poliovaccine. N Engl J Med 1962, 267:1228-1230.
14. Aycock W.L. Tonsillectomy and poliomyelitis. I. Epidemiologic considerations. Medicine 1942, 21:65-94.
15. Aylward B., Yamada T. The polio endgame. N Engl J Med 2011, 364:2273-2275.
16. Baker A.B. Neurologic signs of bulbar poliomyelitis. Poliomyelitis: Papers and Discussions Presented at the First International Poliomyelitis Conference 1949, 241-244. Lippincott, Philadelphia.
17. Baron R.C., Hatch M.H., Eeman K.D., et al. Aseptic meningitis among members of a high school football team. An outbreak associated with echovirus 16 injection. JAMA 1982, 248:1724-1727.
18. Bartfeld H., Dham C., Donnenfeld H., et al. Immunological profile of amyotrophic lateral sclerosis patients and their cell mediated immune responses to viral and CNS antigens. Clin Exp Immunol 1982, 48:137-147.
19. Bass J.W., Halstead S.B., Fischer G.W., et al. Oral poliovaccine effect of booster vaccination one to fourteen years after primary series. JAMA 1978, 239:2252-2255.
20. Beghi E., Nicolosi A., Kurland L.T., et al. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 50-1981: I. Epidemiology. Ann Neurol 1984, 16:283-294.
21. Bell E.J., Russell s.J. Acute transverse myelopathy and ECHO-2 virus infection. Lancet 1963, 2:1226-1227.
22. Belnap D.M., Filman D.J., Trus B.L., et al. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol 2000, 74:1342-1354.
23. Ben-Efraim S., Long D.A. The sensitising power of diphtheria prophylactics in relation to poliomyelitis. Lancet 1957, 2:1033-1035.
24. Bergelson J.M. Receptors. The Picornaviruses 2010, 73-86. ASM, Washington, DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
25. Bergelson J.M., Cunningham J.A., Droguett G., et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
26. Berger J.R., Chumley W., Pittman T., et al. Persistent coxsackie B encephalitis: report of a case and review of the literature. J Neurovirol 2006, 12:511-516.
27. Blinkova O., Rosario L., Li L., et al. Frequent detection of highly diverse species of Cardiovirus, Cosavirus, Bocavirus, and Circovirus in sewage collected in the United States. J Clin Microbiol 2009, 47:3507-3513.
28. Blitzinger K., Anzil A.P. Neural route of infection in viral diseases of the central nervous system. Lancet 1974, 2:1374-1375.
29. Bodensteiner J.B., Morris H.H., Howell J.T., et al. Chronic ECHO type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: treatment with immune plasma. Neurology 1979, 29:815-819.
30. Bodian D. The virus, the nerve cell, and paralysis. A study of experimental poliomyelitis in the spinal cord. Bull Johns Hopkins Hosp 1948, 83:1-106.
31. Bodian D. Poliomyelitis: pathologic anatomy. Poliomyelitis: Papers and Discussions Presented at the First International Poliomyelitis Conference 1949, 62-84. Lippincott, Philadelphia.
32. Bodian D. Second attacks of paralytic poliomyelitis in human beings in relation to immunity, virus type and virulence. Am J Hyg 1951, 54:174-190.
33. Bodian D. Virus and host factors determining the nature and severity of lesions and of clinical manifestations. Poliomyelitis: Papers and Discussions Presented at the Second International Poliomyelitis Conference 1952, 61-87. Lippincott, Philadelphia.
34. Bodian D. Viremia in experimental poliomyelitis. I. General aspects of infection after intravenular inoculation with strains of high and low invasiveness. Am J Hyg 1954, 60:339-357.
35. Bodian D. Emerging concepts of poliomyelitis infection. Science 1955, 122:105-108.
36. Bodian D. Some physiologic aspects of poliovirus infections. Harvey Lect 1956, 52:23-56.
37. Bodian D. Poliomyelitis. Pathology of the nervous system 1972, 2323-2394. McGraw-Hill, New York. J. Minckler (Ed.).
38. Bodian D., Nathanson N. Inhibitory effect of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees. Bull Johns Hopkins Hosp 1960, 107:143-162.
39. Bodian D., Morgan I.M., Howe H.A. Differentiation of types of poliomyelitis virus. III. The grouping of fourteen strains into three basic immunologic types. Am J Hyg 1949, 49:234-235.
40. Bojinov S., Mitov G., Nivov N. Attempted virologic and serologic verification of contemporary acute parkinsonism encephalitis. Nevrol Psikhiatr Nevrokhir 1974, 13:369-378.
41. Bouchard M.F., Lam D.H., Racaniello V.R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 1995, 69:4972-4978.
42. Boulger L.R., Marsden S.A., Magrath D.L., et al. Comparative monkey neurovirulence of Sabin type III poliovirus vaccines. J Biol Stand 1979, 7:97-111.
43. Bowles N.E., Richardson P.J., Olsen E.G.J., et al. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1:1120-1123.
44. Bowles N.E., Oubowitz V., Sewry C.A., et al. Dermatomyositis, polymyositis, and coxsackie-B-virus infection. Lancet 1987, I:1004-1007.
45. Brecht M., Jyoti R., Mcguire W., et al. A case of neonatal coxsackie B virus brainstem encephalitis. J Paediatr Child Health 2010, 46:696-701.
46. Brooksby J.R. Portraits of viruses: foot-and-mouth disease virus. Intervirology 1982, 18:1-23.
47. Brown R.H., Johnson D., et al. Type 1 human poliovirus binds to human synaptosomes. Ann Neurol 1987, 21:64-70.
48. Bubeck D., Filman D.J., Hogle J.M. Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol 2005, 12:615-618.
49. Burns W.H., Billups L.C., Notkins A.L. Thymus dependence of viral antigens. Nature 1975, 256:654-656.
50. Cann A.L.J., Fanway G.S., Hughes P.J., et al. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res 1984, 12:7787-7792.
51. Casey A.E. The incubation period in epidemicpoliomyelitis. JAMA 1942, 120:805-807.
52. Cashman N.R., Maselli R., Wollman R.L., et al. Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med 1987, 317:7-12.
53. Centers for Disease Control Enterovirus surveillance report, 1970-1979 1981.
54. Centers for Disease Control Poliomyelitis surveillance summary, 1980-1981 1982.
55. Centers for Disease Control Annual summary 1981: Reported morbidity and mortality in the United States. Morbid Mortal Wkly Rep 1982, 30:34-36.
56. Centers for Disease Control Poliomyelitis - United States, 1975-1984. Morbid Mortal Wkly Rep 1986, 35:180-182.
57. Centers for Disease Control Acute hemorrhagic conjunctivitis caused by coxsackie A24 variant - Puerto Rico. Morbid Mortal Wkly Rep 1988, 37:123-125.
58. Centers for Disease Control and Prevention Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Morbid Mortal Wkly Rep 1997, 46:1-25.
59. Centers for Disease Control and Prevention Wild poliovirus type 1 and type 3 importations - 15 countries, Africa, 2008-2009. Morbid Mortal Wkly Rep 2009, 58:357-362.
60. Centers for Disease Control and Prevention (CDC) Nonpolio enterovirus and human parechovirus surveillance - United States, 2006-2008. Morbid Mortal Wkly Rep 2010, 59:1577-1580.
61. Centers for Disease Control Aseptic meningitis surveillance, annual summary 1976 1979.
62. Centers for Disease Control Poliomyelitis - Pennsylvania, Maryland. Morbid Mortal Wkly Rep 1979, 28:49-50.
63. Chalhub E.G., Devivo O.C., Siegel B.A., et al. Coxsackie A9 focal encephalitis associated with acute infantile hemiplegia and porencephaly. Neurology 1977, 27:574-579.
64. Charcot J.M., Joffroy A. Cas de paralysie infantile spinale avec lesions des comes anterieures de la substance grise de la moelle epiniere. Arch Physiol Norm Pathol 1870, 3:134.
65. Chiu C.Y., Greninger A.L., Kanada K., et al. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A 2008, 105:14124-14129.
66. Chiu C.Y., Greninger A.L., Chen E.C., et al. Cultivation and serological characterization of a human Theiler's-like cardiovirus associated with diarrheal disease. J Virol 2010, 84:4407-4414.
67. Chonmaitree T., Menegus M.A., Schervishswier Kosz E.M., et al. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics 1981, 67:489-493.
68. Chonmaitree T., Menegus M.A., Powell K.R. The clinical relevance of 'CSF viral culture'. A two year experience with aseptic meningitis in Rochester, N.Y. JAMA 1982, 247:1843-1847.
69. Chopra J.S., Banejuee A.K., Murthy J.M.K., et al. Paralytic rabies: a clinico-pathological study. Brain 1980, 103:789-802.
70. Christodoulou C., Colbere-Garapin F., Macadam A., et al. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 1990, 64:4922-4929.
71. Chumakov M., Voroshilova M., Stanndarov L., et al. 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 1979, 60:329-340.
72. Clemmer D.I., Li F., Leblanc D.R., et al. An outbreak of subclinical infection with coxsackievirus B3 in southern Louisiana. Am J Epidemiol 1966, 83:123-129.
73. Codd M.B., Mulder D.W., Kujuand L.T., et al. Poliomyelitis in Rochester, Minnesota, 1935-1955: epidemiology and long-term sequele: a preliminary report. Late effects of poliomyelitis 1985, 121-134. Miami, Symposia Foundation. F.L. Halstead, D.O. Wiechers (Eds.).
74. Colio L.G., Criley B.R., Coriell L.L. Treatment of poliomyelitis in monkeys with hyperimmune rabbit-globulin. J Immunol 1958, 80:278-281.
75. Committee on the Echo Viruses, National Foundation for Infantile Paralysis Enteric cytopathogenic human orphan (ECHO) viruses. Science 1955, 122:1187-1188.
76. Committee on the Enteroviruses, National Foundation for Infantile PARALYSIS The enteroviruses. Am J Public Health 1957, 47:1556-1566.
77. Cooper J.B., Pratt W.P., English B.K., et al. Coxsackievirus B3 producing fatal meningoencephalitis in a patient with X-linked agammaglobulinemia. Am J Dis Child 1983, 137:82-83.
78. Couch R.B., Douglas R.G., Lindgren K.M., et al. Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol 1970, 91:78-86.
79. Cree B.C., Bernardini G.L., Gays A.P., et al. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003, 60:107-112.
80. Crowell R.L., Landau B.J. Receptors in the initiation of picornavirus infections. Comprehensive virology 1983, vol. 18:1-42. Plenum, New York.
81. Dal Canto M.C., Barbano R.L., Jubelt B. Ultrastructural immunohistochemical localization of poliovirus during virulent infection of mice. J Neuropathol Exp Neurol 1986, 45:613-617.
82. Dalakas M.C., Eldre G., Hallett M., et al. A long term follow-up study of patients with post poliomyelitis neuromuscular symptoms. N Engl J Med 1986, 314:959-963.
83. Dales S., Eggers H.J., Tamm I., et al. Electron microscopic study of the formation of poliovirus. Virology 1965, 26:379-389.
84. Dalldorf G., Sickles G.M. An unidentified, filterable agent isolated from the feces of children with paralysis. Science 1948, 108:61-62.
85. Davis L.E., Bodian D., Price D., et al. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 1977, 297:241-245.
86. Deibel R., Gross L.L., Collins D.N. Isolation of a new enterovirus. Proc Soc Exp Biol Med 1975, 148:203-207.
87. Dery P., Marks M.I., Shapera R. Clinical manifestations of coxsackievirus infections in children. Am J Dis Child 1974, 128:464-468.
88. Devries A.S., Harper J., Murray A., et al. Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med 2011, 364:2316-2323.
89. Dick G.W.A., Haddow A.J., Best A.M., et al. Mengo encephalomyelitis: a hitherto unknown virus affecting man. Lancet 1948, 2:286-295.
90. Dougherty J.D., Park N., Gustin K.E., et al. Interference with cellular gene expression. The Picornaviruses 2010, 165-180. ASM Press, Washington DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
91. Drexler J.F., De Souza Luna L.K., Stocker A., et al. Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerg Infect Dis 2008, 14:1398-1405.
92. Drexler F.J., Baumgarte S., De Souza Luna L.K., et al. Genomic features and evolutionary constraints in Saffold-like cardioviruses. J Gen Virol 2010, 91:1418-1427.
93. Drexler J.F., Baumgarte S., Eschback-Bludau M., et al. Human cardioviruses in pediatric patients with meningitis and sudden infant death syndrome. Emerg Infect Dis 2011, 17:2313-2315.
94. Dulbecco R., Vogt M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med 1954, 99:167-182.
95. Editorial Virus meningitis. Br Med J 1978, 2:1451-1452.
96. Editorial Neurovirulence of enterovirus 70. Lancet 1982, 1:373-374.
97. Editorial Avoiding the danger of enteroviruses to newborn infants. Lancet 1986, 1:194-195.
98. Editorial The chronic fatigue syndrome - one entity or many?. N Engl J Med 1988, 319:1726-1728.
99. Egger J., Lingam S., Erdohazi M., et al. Progressive spastic paraplegia due to persistent echovirus encephalomyelitis in a child with X-linked hypogammaglobulinemia. J Neurol Neurosurg Psychiatry 1982, 45:564-565.
100. El-Hagrassy M.M.O., Banatvala J.E., Coltart D.J. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet 1980, 2:1160-1162.
101. Elves M.W., Jloath S., Israels M.C.G. The response of lymphocytes to antigen challenge in vitro. Lancet 1963, 1:806-807.
102. Enders J.F., Weller T.H., Robbins F.C. Cultivation of Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949, 109:85-87.
103. Erlendsson K., Swartz T., Dwyer J.M. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin. N Engl J Med 1985, 312:351-353.
104. Evans D.M.A., Dunn G., Minor P.D., et al. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (Lond) 1985, 314:548-550.
105. Farmer K., Macarthur B.A., Dezoete J.A., et al. A case of agammaglobulinemia complicated by meningoencephalitis due to echo virus 27. Aust Paediatr J 1984, 20:229-232.
106. Feigin R.D., Shackelford P.G. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973, 289:571-574.
107. Feldman W., Larke R.P. Acute cerebellar ataxia associated with the isolation of coxsackie type A9. Can Med Assoc J 1972, 106:1104-1107.
108. Fenner R., McAuslan B.R., Mims C.S., et al. The Biology of Animal Viruses 1974, Academic Press, New York.
109. Flodstrom-Tullberg M., Hultcrantz M., Stotland A., et al. RNase and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 2005, 174:1171-1177.
110. Foley K.M., Beresford R.H. Acute poliomyelitis beginning as transverse myelopathy. Arch Neurol 1974, 30:182-183.
111. Foley J.F., Chin T.D.Y., Gravell C.R. Paralytic disease due to infection and ECHO virus type 9: report of a case with residual paralysis. N Engl J Med 1959, 260:924-926.
112. Forbes S.J., Brumlik J., Harding H.B. Acute ascending polyradiculomyelitis associated with ECHO 9 virus. Dis Nerv Syst 1967, 28:537-540.
113. Ford D.J., Ropka S.L., Collins G.H., et al. The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis. Microb Pathog 2002, 33:97-107.
114. Fox J.P. Eradication of poliomyelitis in the United States: a commentary on the Salk reviews. Rev Infect Dis 1980, 2:277-281.
115. Fox J.P., Gelfand H.M., Leblanc D.R., et al. The spread of vaccine strains of poliovirus in the household and in the community in southern Louisiana. Poliomyelitis: Papers and Discussions Presented at the Fifth International Poliomyelitis Conference 1961, 368-383. Lippincott, Philadelphia.
116. Frantzidou F., Kamaria F., Dumaidi K., et al. Aseptic meningitis and encephalitis because of herpesviruses and enteroviruses in an immunocompetent adult population. Eur J Neurol 2008, 15:995-997.
117. Fu Y.C., Chi C.S., Hsu S.L., et al. Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child 2004, 89:368-371.
118. Furesz J., Armstrong R.E., Contreras G. Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. Lancet 1978, 2:1248.
119. Gajdusek C.C. Review article: encephalomyocarditis virus infection in childhood. Pediatrics 1955, 16:902-906.
120. Galama J., Lanke K., Zoll J., et al. Seroepidemiology of Safford cardiovirus type 2. Emerg Infect Dis 2011, 17:1572-1573.
121. Gauntt C.J., Paque R.E., Trousdale M.D., et al. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun 1983, 851-864.
122. Gear J.H. Nonspecific causes of polio-like paralytic syndromes. Rev Infect Dis 1984, 6(Suppl. 2):S379-S384.
123. Gear J.H.S., Measroch V. Coxsackievirus infections of the newborn. Prog Med Virol 1973, 15:42-62.
124. Gelfand H.M., Leblanc D.R., Fox J.P. Studies on the development of natural immunity to poliomyelitis in Louisiana II. Description and analysis of episodes of infection observed in study group households. Am J Hyg 1957, 65:367-385.
125. Ghendon Y.Z., Sanakoyeva I.I. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin strain) in persons after naturally and experimentally acquired immunity. Acta Virol 1961, 5:265-273.
126. Gondo K., Kusuhara K., Take H., et al. Echovirus type 9 epidemic in Kagoshima, southern Japan: seroepidemiology and clinical observation of aseptic meningitis. Pediatr Infect Dis J 1995, 14:787-791.
127. Goto K., Sanefuji M., Kusuhara K., et al. Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis 2009, 15:1689-1691.
128. Graybill J.R., Silva J., O'Brien M.S., et al. Epidemic neuromyasthenia:a syndrome or disease?. JAMA 1972, 219:1440-1443.
129. Green W.T. The management of poliomyelitis: the convalescent stage. Poliomyelitis: Papers and Discussions Presented at the First International Poliomyelitis Conference 1949, 165-185. Lippincott, Philadelphia.
130. Greve J.M., Davis G., Meyer A.M., et al. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56:839-847.
131. Grist N.R., Bell E.J. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev Infect Dis 1984, 6(Suppl. 2):S308-S386.
132. Grist N.R., Bell E.J., Asaad F. Enteroviruses in human disease. Prog Med Virol 1978, 24:114-187.
133. Gromeier M., Bossert B., Arita M., et al. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol 1999, 73:958-964.
134. Guest S., Pilipenko E., Sharma K., et al. Molecular mechanisms of attenuation of the Sabin strain of PV type 3. J Virol 2004, 78:11097-11107.
135. Gust I.D., Lehmann N.I., Lucas C.R. Relationship between prevalence of antibody to hepatitis A antigen and age: a cohort effect?. J Infect Dis 1978, 38:425-426.
136. Guyer B., Bisong A.A.E., Gould J., et al. Injections and paralytic poliomyelitis in tropical Africa. Bull World Health Organ 1980, 58:285-291.
137. Gwaltney J.M. Rhinoviruses. Viral infections of humans: epidemiology and control 1982, 91-517. Plenum, New York. A.S. Evans (Ed.).
138. Hadfield M.G., Seidun M., Houff S.A., et al. Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin. J Neuropathol Exp Neurol 1985, 44:520-529.
139. Hall C.E., Cooney M.I.C., Fox J.P. The Seattle Virus Watch Program. I. Infection and illness experience of Virus Watch families during a community-wide epidemic of enterovirus type 30 aseptic meningitis. Am J Public Health 1970, 60:1456-1465.
140. Halonen P., Rosen L., Huebner R.J. Homologous and heterologous complement fixing antibody in persons infected with ECHO, coxsackie, and poliomyelitis cases. Proc Soc Exp Biol Med 1959, 101:236-241.
141. Halstead L.S., Wiechers D.O., Rossi C.D. Late effects of poliomyelitis: a national survey. Late effects of poliomyelitis 1985, 11-31. Miami, Symposia Foundation. L.S. Halstead, D.O. Wiechers (Eds.).
142. Hammond W.M., Ludwig E.H. Possible protective effect of previous type 2 infections against paralytic poliomyelitis due to type 1 virus. Am J Hyg 1957, 66:274-280.
143. Hara M., Saito Y., Komatsu T., et al. Antigenic analysis of polio viruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiol Immunol 1981, 25:905-913.
144. Hashimoto I., Hagiwara A. Studies on the pathogenesis of and propagation of enterovirus 71 in poliomyelitis-like disease in monkeys. Acta Neuropathol 1982, 58:125-132.
145. Hashimoto I., Hagiwara A., Komatsu T. Ultrastructural studies on the pathogenesis of poliomyelitis in monkeys infected with poliovirus. Acta Neuropathol 1984, 64:53-60.
146. Hays A.P., Gamboa E.T. Acute viral myositis. Myology 1986, Vol. 2:1439-1466. McGraw-Hill, New York.
147. Heine I. Beobachtungen uber Lhmungszustande der unteren Extremitaten und deren Behandlung 1840, Kohler, Stuttgart.
148. Hewat E.A., Blaas D. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating. J Virol 2004, 78:2935-2942.
149. Hill A.B., Knowelden J. Inoculation and poliomyelitis: A statistical investigation in England and Wales in 1949. Br Med J 1950, 2:1-6.
150. Himeda T., Ohara Y. Saffold virus, a novel human cardiovirus with unknown pathogenicity. J Virol 2012, 86:1292-1296.
151. Ho M. Acute viral encephalitis. Handbook of clinical neurology, vol. 34. Infections of the nervous system, Part II 1978, 63-82. Amsterdam, North Holland Publishing Co. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
152. Hogle J.M., Cho M., Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 1985, 229:1358-1365.
153. Holmes G.P., Kaplan J.E., Stewart J.A., et al. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?. JAMA 1987, 257:2297-2302.
154. Holmes G.P., Kaplan J.E., Gantz N.M., et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988, 108:387-389.
155. Honig E.I., Melnick J.L., Isacson P., et al. An endemiological study of enteric virus infections: poliomyelitis, coxsackie, and orphan (ECHO) viruses isolated from normal children in two socioeconomic groups. J Exp Med 1956, 103:247-262.
156. Horstmann D.M. Acute poliomyelitis: relation of physical activity at the time of onset to the course of the disease. J Amer Med Ass 1950, 142:236-241.
157. Horstmann D.M. The epidemiology and pathogenesis of poliomyelitis. Bull N Y Acad Med 1953, 29:910-929.
158. Horstmann D.M. Poliomyelitis: severity and type of disease in different age groups. Ann New York Acad Sci 1955, 61:956-967.
159. Horstmann D.M. Epidemiology of poliomyelitis and allied diseases - 1963. Yale J Biol Med 1963, 36:5-26.
160. Horstmann D.M., Paul J.R. The incubation period in human poliomyelitis and its implications. JAMA 1947, 135:11-14.
161. Horstmann D.M., Yamada N. Enterovirus infections of the central nervous system. Association for research in nervous and mental disease: infections of the nervous system. Proceedings of the Association, 1964, New York, NY (Research Publications Vol. XLIV) 1968, 236-253. Williams and Wilkins, Baltimore. H.M. Zimmerman (Ed.).
162. Horstmann D.M., Ward R., Melnick J.L. The isolation of poliomyelitis virus from extraneural sources. III. Persistence of virus in stools after acute infection. J Clin Invest 1946, 25:278-283.
163. Horstmann D.M., Emmons J., Gimpel L., et al. Enterovirus surveillance following a community-wide oral poliovirus vaccination program: a seven-year study. Am J Epidemiol 1973, 97:173-186.
164. Hovi T., Cantell K., Houvilainen A., et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986, 1:1427-1432.
165. Hovi T., Stenvik M., Kinnunen E. Diagnosis of poliomyelitis by demonstration of intrathecal synthesis of neutralizing antibodies. J Infect Dis 1986, 153:998-999.
166. Howe H.A., Wilson J.L. Poliomyelitis. Viral and rickettsial infections of man 1959, 432-478. Lippincott, Philadelphia. 3rd edn. T.M. Rivers, F.L. Horsfall (Eds.).
167. Huang C.C., Liu C.C., Chang Y.-C., et al. Neurological complications in children with enterovirus 71 infection. N Engl J Med 1999, 341:936-942.
168. Huber S.A., Gauntt C.J., Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res 1998, 51:35-80.
169. Hughes P.J., Evans D.M.A., Minor P.D., et al. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J Gen Virol 1985, 66:309-316.
170. Hung T., Kono R. Neurological complications of acute haemorrhagic conjunctivitis (a polio-like syndrome in adults). Handbook of clinical neurology, vol. 38, Neurological manifestations of systemic diseases, part I 1979, 595-623. North-Holland Publishing Co, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
171. Hung T.P., Sung S.M., Uang H.C., et al. Radicu1omyelitis following acute haemorrhagic conjunctivitis. Brain 1976, 99:771-790.
172. Huovilainen A., Hovi T., Kinnunen L., et al. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J Gen Virol 1987, 68:1373-1378.
173. Ida-Hosonuma M., Iwasaki T., Yoshikawa T., et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 2005, 79:4460-4469.
174. Iizuka N.S., Kuge S., Nomoto A. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 1987, 156:64-73.
175. Ishimauer Y., Nakano S., Yamaoka K., et al. Outbreaks of hand, foot and mouth disease by enterovirus 71: high incidence of complicating disorders of central nervous system. Arch Dis Child 1980, 55:583-588.
176. Itagaki T., Abiko C., Ideka T., et al. Sequence and phylogenetic analyses of Saffold cardiovirus from children with exudative tonsillitis in Yamagat, Japan. Scand J Infect Dis 2010, 42:950-952.
177. Jeha L.E., Sila C.A., Lederman R.J., et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003, 61:55-59.
178. Jenista J.A., Powell K.R., Menegus M.A. Epidemiology of neonatal enterovirus infection. J Pediatr 1984, 104:685-690.
179. Jenkins O., Booth J.D., Minor P.D., et al. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the picornaviridae. J Gen Virol 1987, 68:1835-1848.
180. Jeong E.J., Lee J.H., Kim M.S., et al. Molecular characterization of enteroviruses detected in Gyeong-Ju and Po-Hang provinces of Korea in 2003. Arch Virol 2010, 155:1707-1712.
181. Johnson R.T. Viral infections of the nervous system 1998, Raven Press, New York. 2nd edn.
182. Johnson D.A., Egar A.W. Myelitis associated with an echo virus. JAMA 1967, 201:143-144.
183. Johnson R.T., Shuey H.E., Buescher E.L. Epidemic central nervous system disease of mixed enterovirus etiology. Am J Hyg 1960, 71:321-341.
184. Johnson P.R., Edward K.M., Wright P.F. Failure of intraventricular gamma globulin to eradicate echovirus encephalitis in a patient with X-linked agammaglobulinemia. N Engl J Med 1985, 313:1546-1547.
185. Jones M.S., Lukashov V.V., Ganac R.D., et al. Discovery of a novel human picornavirus from a pediatric patient presenting with fever of unknown oridin. J Clin Microbiol 2007, 45:2144-2150.
186. Jubelt B. Enterovirus and mumps virus infections of the nervous system. Neurol Clin 1984, 2:187-213.
187. Jubelt B. Post-polio syndrome. Curr Treat Options Neurol 2004, 6:87-93.
188. Jubelt B. Viral infections and post viral syndromes. Merritt's neurology 2010, 156-185. Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, PA. 12th edn. L.P. Rowland, T.A. Pedley (Eds.).
189. Jubelt B. Parasitic infections. Merritt's neurology 2010, 228-238. Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, PA. 12th edn. L.P. Rowland, T.A. Pedley (Eds.).
190. Jubelt B. Bacterial infections. Merritt's neurology 2010, 125-147. Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, PA. 12th edn. L.P. Rowland, T.A. Pedley (Eds.).
191. Jubelt B. Enterovirus infections. Viral infections of the human nervous system 2013, 117-142. Springer, New York. A.C. Jackson (Ed.).
192. Jubelt B., Cashman N.R. Neurological manifestations of post-polio syndrome. Crit Rev Neurobiol 1987, 3:199-220.
193. Jubelt B., Lipton H.L. Lansing poliovirus infection in mice: antibody demonstrable by enzyme linked immunosorbent assay (ELISA) and immunopreciptions but not by neutralization. J Neuroimmunol 1987, 14:109-121.
194. Jubelt B., Gallez-Hawkins G., Narayan O., et al. Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol 1980, 39:138-148.
195. Jubelt B., Narayan O., Johnson R.T. Pathogenesis of human poliovirus infection in mice. II. Age dependency of paralysis. J Neuropathol Exp Neurol 1980, 39:149-159.
196. Jubelt B., Goldfarb S.J., Paradise M.J., et al. Fast axonal transport of human. Poliovirus (HPV) (abstract). Neurology 1986, 36(Suppl. 1):204.
197. Jubelt B., Ropka S.L., Goldfarb S.J., et al. Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system. J Neuroimmunol 1989, 21:223-232.
198. Jubelt B., Wilson A.K., Guidiner P.L., et al. Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril. J Infect Dis 1989, 159:866-871.
199. Jubelt B., Mihai C., Li T.M., et al. Rhombencephalitis/brainstem encephalitis. Curr Neurol Neurosci Rep 2011, 11:543-552.
200. Kanagarajan K., Ganesh S., Alakhras M., et al. West Nile virus infection presenting as cerebellar ataxia and fever: case report. South Med J 2003, 96:600-601.
201. Kaplan M.H., Klein S.W., Mcphee J., et al. Group B coxsackie virus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983, 5:1019-1032.
202. Katiyar B.C., Misra S., Singh R.B., et al. Adult polio-like syndrome following enterovirus 70 conjunctivitis (natural) history of the disease. Acta Neurol Scand 1983, 67:263-274.
203. Kauder S.E., Racaniello V.R. Poliovirus tropism and attenuation are determined after internal ribosome entry. J Clin Invest 2004, 113:1743-1753.
204. Kawai T., Akira S. Innate immune recognition of viral infection. Nat Immunol 2006, 7:131-137.
205. Keller R., Dwyer J., Oh W., et al. Intestinal lgA neutralizing antibodies in newborn infants following poliovirus immunization. Pediatrics 1969, 43:330-338.
206. Kessel J.F., Pait C.F. Differentiation of three groups of poliomyelitis virus. Proc Soc Exp Biol Med 1949, 70:315-316.
207. Kew O.M., Noitay B.K., Hatch M.A., et al. Multiple genetic changes can occur in oral polioviruses upon replication in humans. J Gen Virol 1981, 56:337-347.
208. Khatib R., Hatib G.K., Chason J.L., et al. Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum. J Gen Virol 1983, 64:231-236.
209. Kim-Farley R.J., Bart K.J., Schonberger L.B., et al. Poliomyelitis in the USA: virtual elimination of the disease caused by wild virus. Lancet 1984, 2:1315.
210. Kirkegaard K., Semler B.L. Genome replication II: the process. The Picornaviruses 2010, ASM Press, Washington, DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
211. Kitamura N., Semler B., Rothberg P.G., et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 1981, 291:547-553.
212. Klawans H.L., Goetz C. Aseptic meningitis. Handbook of clinical neurology, vol. 34. Infections of the nervous system, part II 1978, 83-91. North-Holland Publishing, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
213. Klingman J., Chui H., Corgiat M., et al. Functional recovery: a major risk factor for the development of postpoliomyelitis muscular atrophy. Arch Neurol 1988, 45:645-647.
214. Knowles N.J., Hovi T., Hyypia T., et al. Picornaviridae. Virus taxonomy: classification and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses 2012, 855-880. Elsevier, San Diego. A.M.Q. King, M.J. Adams, E.B. Carsten, E.J. Lefkowitz (Eds.).
215. Kogon A., Spigland J., Frothingham T.T., et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 1969, 89:51-61.
216. Kono R., Uchida N., Sasagawa A., et al. Neurovirulence of acute hemorrhagic conjunctivitis in virus in monkeys. Lancet 1973, 1:61-63.
217. Koopman F.S., Uegaki K., Gilhus N.E., et al. Treatment for postpolio syndrome. Cochrane Database Syst Rev 2011, 2. CD007818.
218. Koskiniemi M., Vaheri A. Acute encephalitis of viral origin. Scand J Infect Dis 1982, 14:181-187.
219. Kott E., Livni E., Zamir R., et al. Cell mediated immunity to polio and HLA antigens in amyotrophic lateral sclerosis. Neurology 1979, 29:1040-1044.
220. Kuban K.C., Ephros M.A., Freeman R.L., et al. Syndrome of opsoclonus-myoclonus caused by coxsackie B3 infection. Ann Neurol 1983, 13:69-71.
221. Kuge S., Nomoto A.K. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol 1987, 61:1478-1487.
222. Kuntzer T., Bogousslavsky J., Regli F. Encephalite "benigne" du tronc cerebral. Rev Neurol (Paris) 1987, 143:737-745.
223. Kupila L., Vuorinen T., Vainionpaa R., et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006, 66:75-80.
224. La Monica N., Meriam C., Racaniello V.R. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol 1986, 56:515-525.
225. La Monica N., Almond J.W., Racaniello V.R. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol 1987, 61:2917-2920.
226. La Monica N., Kupsky W.J., Racaniello V.R. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies. Virology 1987, 161:429-437.
227. Landsteiner K., Popper E. Obertragung der Poliomyelitis acuta auf Affen. Z Immunitatsforsch 1909, 2:377-390.
228. Lansdown A.B.O. Viral infections and diseases of the heart. Prog Med Virol 1978, 24:70-113.
229. Lee B.E., Davies H.D. Aseptic meningitis. Curr Opin Infect Dis 2007, 20:272-277.
230. Lehan K.P.H., Chick E.W., Doto l.L., et al. An epidemic illness associated with a recently recognized enteric virus (Echovirus type. 4). I. Epidemiologic and clinical features. Am J Hyg 1957, 66:63-75.
231. Lepow M.L., Coyne N., Thompson B., et al. A clinical epidemiological and laboratory investigation of aseptic meningitis during the four year period 1955-1958. II. The clinical disease and its sequelae. N Engl J Med 1962, 266:1188-1193.
232. Lerner M., Sun S.H., Rausen A.R., et al. Viral meningitis: epidemic in children on lower east side of New York City. New York State J Med 1978, 78:746-750.
233. Levinson S.O., Milzer A., Lewin P. Effect of fatigue, chilling and mechanical trauma on resistance to experimental poliomyelitis. Am J Hyg 1945, 42:204-213.
234. Liao H.T., Hung K.L. Neurologic involvement in an outbreak of enterovirus 71 infection: a hospital-based study. Acta Paediatr Taiwan 2001, 42:27-32.
235. Lindberg A.M., Stalhandske P.O., Pettersson U. Genome of coxsackievirus B3. Virology 1987, 156:50-63.
236. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease leading to demyelination. Infect Immun 1975, 11:1147-1155.
237. Lipton H.L., Friedmann A. Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence. J Virol 1980, 33:1165-1172.
238. Lipton M.M., Steigman A.J., Dizon F.C. Poliovirus neutralizing antibody in cerebrospinal fluid. J Infect Dis 1965, 115:356-362.
239. Liu O.C., Carter J.E., Desanctis A.N., et al. A study of the effect of antiserum on poliovirus infection induced by the intraspinal inoculation of rhesus monkeys. J Immunol 1958, 80:106-113.
240. Liu O.C., Carter J.E., Sanders B.E., et al. A study of serotherapy of poliomyelitis in rhesus monkeys. Br J Exp Pathol 1959, 40:133-144.
241. Liu C.C., Tseng H.W., Wang S.M., et al. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol 2000, 17:23-30.
242. Lloyd A.R., Phales J.P., Gandevia S.C. Muscle strength, endurance and recovery in the post infection fatigue syndrome. J Neurol Neurosurg Psychiatry 1988, 51:1316-1322.
243. Lo C.W., Wu K.G., Lin M.C., et al. Application of molecular methods for the classification of human enteroviruses and its correlation with clinical manifestations. J Microbiol Immunol Infect 2010, 43:354-359.
244. Loeffler R., Frosch P. Report of the Commission for Research on Foot-and-Mouth disease. Centralbl Bakt Parisit Infekt Part I 1898, 23:371-391. Reprinted in: Hanon N (Ed.), (1964). Translation in: Selected papers on virology. Prentice Hall, Englewood Cliffs, N.J., pp. 64-68.
245. Luo M., Vriend G., Kamer G., et al. The atomic structure of mengovirus at 3.0 A resolution. Science 1987, 235:182-191.
246. Macejak D.G., Sarnow P. Internal initiation of translation mediated by the 5' leader of a cellular mRNA. Nature 1991, 353:90-94.
247. Mahon B.P., Katrak K., Mills K.H. Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones. J Virol 1992, 66:7012-7020.
248. Malcolm B.S., Eiden J.J., Hendley J.O. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics 1980, 65:725-726.
249. Marine W.M., Chen T.D.Y., Gravelle C.R. Limitation of fecal and pharyngeal poliovirus excretion in Salk vaccinated children. Am J Hyg 1962, 76:173-195.
250. Marsden S.A., Boulger S.R., Macgrath D.I., et al. Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines. J Biol Stand 1980, 8:303-309.
251. Martin A., Wychowski C., Couderc T., et al. Engineering a polivirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J 1988, 7:2839-2847.
252. Martinez-Salas E., Ryan M.D. Translation and protein processing. The Picornaviruses 2010, 141-161. ASM Press, Washington, DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
253. Matthews R.E.F. Classification and nomenclature of viruses. Intervirology 1982, 17:1-200.
254. McCallister R.M., Hummeler K., Coriell L.L. Acute cerebellar ataxia: report of a case with isolation of type 9 ECHO virus from the cerebrospinal fluid. N Engl J Med 1959, 261:1159-1162.
255. McCartney R.A., Banatvala J.E., Bell E.J. Routine use of u-antibody-capture ELISA for the serological diagnosis of coxsackie B virus infections. J Med Virol 1986, 19:205-212.
256. Mccloskey B.P. The relation of prophylactic inoculations to the onset of poliomyelitis. Lancet 1950, 1:659-663.
257. Mckinley M.T., Miralles J.V., Brisson C.J., et al. Prevention of human poliovirus-induced paralysis and death in mice by the novel antiviral agent arildone. Antimicrob Agents Chemother 1982, 22:1022-1025.
258. Mckinney R.E., Katz S.L., Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987, 9:334-356.
259. Mease P.J., Ochs H.D., Wedgewood R.J. Successful treatment of echovirus meningoencephalitis and myositis-fascitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 1981, 304:1278-1281.
260. Medin O. Ueber eine Epidemie van spinaler Kinkerlahmung. Ver. X Int. Med. Kongr., 2, Abt. 1891, 6:37-47.
261. Melnick J.L. Echoviruses. Viral and rickettsial infections of man 1965, 513-545. Lippincott, Philadelphia. 4th edn. F.L. Horsfall, I. Tamm (Eds.).
262. Melnick J.L. Towards the eradication of poliomyelitis. Medical virology: Proceedings of the International Symposium on Medical Virology 1981, 261-299. Elsevier Biomedical Division, New York. L.M. deLaMasa, E.M. Peterson (Eds.).
263. Melnick J.L. Classification of hepatitis A virus as enterovirus type 72 and hepatitis B virus as hepadnavirus type 1. Intervirology 1982, 18:105-106.
264. Melnick J.L. Portraits of viruses: the picomaviruses. Intervirology 1983, 20:61-100.
265. Melnick J.L. Enteric viruses in water. Monographs in Virology 1984, Vol. 15. Karger, Basel.
266. Melnick J.L. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis 1984, 6:S387-S390.
267. Melnick J.L. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. Virology 1985, 739-794. Raven Press, New York. B.N. Fieldst, D.M. Knipe, R.M. Cbanock (Eds.).
268. Melnick J.L. Poliovirus and other enteroviruses. Viral infections of humans 1997, 583-663. Plenum, New York. 4th Ed. A.S. Evans, R.A. Kaslow (Eds.).
269. Melnick J.L., Agren K. Poliomyelitis and Coxsackie viruses isolated from normal infants in Egypt. Proc Soc Exp Biol Med 1952, 81:621-624.
270. Melnick J.L., Shaw E.W., Curnen E.C. A virus isolated from patients diagnosed as nonparalytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med 1949, 71:344-349.
271. Melnick J.L., Emmons J., Coffey J.H., et al. Seasonal distribution of coxsackieviruses in urban sewage and flies. Am J Hyg 1954, 59:164-184.
272. Melnick J.L., Paul J.K., Walton M. Serologic epidemiology of poliomyelitis. Am J Public Health 1955, 45:429-437.
273. Melnick J.L., Cockburn W.C., Dalldorf G., et al. Picornavirus group. Virology 1963, 19:114-116.
274. Melnick J.L., Proctor R.O., Ocampo A.R., et al. Free and bound virus in serum after administration of oral poliovirus vaccine. Am J Epidemiol 1966, 84:329-342.
275. Melnick J.L., Wenner H.A., Pwwps C.A. Enteroviruses. Diagnostic procedures for viral, rickettsial and chlamydial infections 1979, 471-534. American Public Health Association, Washington. 5th edn. E.H. Lennette, N.J. Schmidt (Eds.).
276. Melnick J.L., Schmidt N.J., Mirkovic R.R., et al. Identification of Bulgarian strain 258 of enterovirus 71. Intervirology 1979, 12:297-302.
277. Melnick J.L., Ledinko N. Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period: the ratio of inapparent infections to clinical poliomyelitis. Am J Hyg 1953, 58:207-222.
278. Mendelson C.L., Wimmer E., Racaniello V.R. Celluar receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56:855-865.
279. Mendez-Gusbion P., Sanchez-Longo L.F., Valcarcel M., et al. Acute cerebellar ataxia in children associated with infection by poliovirus I. Pediatrics 1962, 29:808-815.
280. Meyer H.M., Johnson R.T., Crawford I.P., et al. Central nervous system syndromes of 'viral' etiology: a study of 713 cases. Am J Med 1960, 29:334-347.
281. Minor P.D. The polio-eradication programme and issues of the end game. J Gen Virol 2012, 93:457-474.
282. Mintz L., Drew L.W. Relation of culture site to the recovery of nonpolio enteroviruses. Am J Clin Pathol 1980, 74:324-326.
283. Modlin J.F. Perinatal echovirus infections: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986, 8:918-926.
284. Modlin J.F., Dagan R., Berlin L.E., et al. Focal encephalitis with enterovirus infections. Pediatrics 1991, 88:841-845.
285. Moore M. From the Centers for Disease Control: enteroviral disease in the U.S., 1970-1979. J Infect Dis 1982, 146:103-108.
286. Moore M., Morens D.M. Enteroviruses, including polioviruses. Textbook of human virology 1984, 407-483. PSG Publishing, Littleton. R.B. Belshe (Ed.).
287. Moore M., Baron R.C., Filstein M.R., et al. Aseptic meningitis and high school football players, 1978 and 1980. JAMA 1983, 249:2039-2042.
288. Morens D.M., Pallansch M.A., Moore M. Polioviruses and other enteroviruses. Textbook of Human Virology 1991, 427-497. Mosby Year Book, St Louis. R.B. Belshe (Ed.).
289. Morgan I.M. The role of antibody in experimental poliomyelitis. III: Distribution of antibody in and out of the central nervous system in paralyzed monkeys. Am J Hyg 1947, 45:390-400.
290. Morgan I.M. Level of serum antibody associated with intracerebral immunity in monkeys vaccinated with Lansing poliomyelitis virus. J Immunol 1949, 62:301-310.
291. Mulder D.W., Rosenbaum R.A., Layton D.D. Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis?. Mayo Clin Proc 1972, 47:756-761.
292. Murray K.E., Barton D.J. Poliovirus CRE-dependent VPg uridylylation of positive-strand RNA synthesis but for negative-strand RNA synthesis. J Virol 2003, 77:4739-4750.
293. Murray M.G., Bradley J., Yang X.-F., et al. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 1988, 241:213-215.
294. Nagy G., Takatsy S., Kukan E., et al. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in I 978. Arch Virol 1982, 71:217-227.
295. Nakano J.H., Hatch M.H., Thieme M.L., et al. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 1978, 24:178-206.
296. Nathanson N., Bodian D. Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block of a neurotropic and pantropic strain. I. The effect of neural block of a neurotropic and pantropic strain. Bull Johns Hopkins Hosp 1961, 108:308-319.
297. Nathanson N., Bodian D. Experimental poliomyelitis following intramuscular virus injection. II. Viremia and the effect of antibody. Bull Johns Hopkins Hosp 1961, 108:320-333.
298. Nathanson N., Bodian D. Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. Bull Johns Hopkins Hosp 1962, III:198-220.
299. Nathanson N., Martin J.R. The epidemiology of poliomyelitis: Enigmas surrounding its appearance, epidemicity and disappearance. Am J Epidemiol 1979, 110:672-692.
300. Neznanov N., Chumakov K.M., Neznanova L., et al. Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 2005, 280:24153-24158.
301. Nicolosi A., Hauser W.A., Begffi E., et al. Epidemiology of the central nervous system infections in Olmsted County, Minnesota, 1950-1981. J Infect Dis 1986, 154:399-408.
302. Nielsen A.C., Bottiger B., Banner J., et al. Serious invasive Saffold virus infections in children, 2009. Emerg Infect Dis 2012, 18:7-12.
303. Nokowane B.M., Wassilak S.G.F., Orenstein W.A., et al. Vaccine associated paralytic poliomyelitis: United States: 1973 through 1984. JAMA 1987, 257:1335-1340.
304. Nolan I.P., Wumer B.J., Melnick J.L. Poliomyelitis: its highly invasive nature and narrow stream of infection in a community of high socioeconomic level. N Engl J Med 1955, 253:945-954.
305. Nomoto A., Omata T., Toyoda H., et al. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A 1982, 79:5793-5797.
306. Noordhoek G.T., Weel J.F., Poelstra E., et al. Clinical validation of a new real-time PCR asay for detection of enteroviruses and parechoviruses, and implications for diagnostic procedures. J Clin Virol 2008, 41:75-80.
307. Nottay B.K., Kew O.M., Hatch M.H., et al. Molecular variation of type 1 vaccine related and wild polioviruses during replication in humans. Virology 1981, 108:405-423.
308. Oberste M.S., Gotuzzo E., Blair P., et al. Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg Infect Dis 2009, 15:640-646.
309. Ogra P.L. Distribution of echovirus antibody in serum, nasopharynx, rectum and spinal fluid after natural infection with echovirus type 6. Infect Immun 1970, 2:150-155.
310. Ogra P.L. Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med 1971, 284:59-64.
311. Ogra P.L., Karzon D.T. Distribution of polio virus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol 1969, 102:1423-1430.
312. Ogra P.L., Karzon D.T. Formation and function of poliovirus antibody in different tissues. Prog Med Virol 1971, 13:156-193.
313. Ogra P.L., Karzon D.T., Righthand F., et al. Immunoglobulin response in serum and secretions after immunization with live and inactivated polio vaccine and natural infection. N Engl J Med 1968, 279:893-900.
314. Ogra P.L., Ogra S.S., Al-Nakeed S. Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys. Infect Immun 1973, 8:931-937.
315. Ohka S., Matsuda N., Tohyama K., et al. Receptor (CD155) dependent endocytosis of PV and retrograde axonal transport of the endosom. J Virol 2004, 78:7186-7198.
316. Olin G. The epidemiologic pattern of poliomyelitis in Sweden from 1905 to 1950. Poliomyelitis: Papers and Discussions Presented at the Second International Poliomyelitis Conference 1952, 367-375. Lippincott, Philadelphia.
317. Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010, 9:1097-1105.
318. Oostvogel P.M., van ijngaarden J.K., van der Avoort H.G., et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994, 344:665-670.
319. Ornata T., Kohara M., Kuge S., et al. Genetic analysis of the attenuation phenotype of poliovirus type I. J Virol 1986, 58:248-358.
320. Pacsa S., Werbljnska J. Natural immunity of Ghanaian children to polio and coxsackieviruses: Brief report. Arch Gesamte Virusforsch 1971, 33:192-193.
321. Page G.S., Mosser A.G., Hogle J.M., et al. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol 1988, 62:1781-1794.
322. Paque R.E., Gauntt C.J., Nealson T.J. Assessment of cell-mediated immunity against coxsackievirus B3 induced myocarditis in a primate model (Papto papto). Infect Immun 1981, 31:470-479.
323. Parker W., Wilt J.C., Dawson J.W., et al. Landry-Guillain-Barré syndrome - the isolation of an ECHO virus type 6. Can Med Assoc J 1960, 82:813-815.
324. Parks W.P., Quieroga L.T., Melnick J.L. Studies of infantile diarrhea in Karachi Pakistan. II. Multiple virus isolations from rectal swabs. Am J Epidemiol 1967, 85:469-478.
325. Patriarca P.A., Onorato I.M., Sklar V.E., et al. Acute hemorrhagic conjunctivitis: investigation of a large-scale community outbreak in Dade County, FL. JAMA 1983, 249:1283-1289.
326. Paul J.R. Epidemiology of poliomyelitis. Monograph series no. 26 1955, WHO, Geneva.
327. Paul J.R. History of poliomyelitis 1971, Yale University Press, New Haven.
328. Paul J.R., Melnick J.L., Barnett V.H., et al. A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg 1952, 55:402-413.
329. Paul J.R., Horstmann D.M., Riordan J.T., et al. An oral poliovirus vaccine trial in Costa Rica. Bull World Health Organ 1962, 26:311-329.
330. Peart A.F.W. An outbreak of poliomyelitis in Canadian Eskimos in wintertime. Can J Public Health 1949, 10:405-417.
331. Peters A.C.B., Vielvoyem G.H.M., Veerstag J., et al. Echo 25 focal encephalitis and subacute hemichorea. Neurology 1979, 29:676-681.
332. Pevear D.C., Oh C.K., Cunningham L.L., et al. Localization of genomic region specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2. J Gen Virol 1990, 71:43-52.
333. Pezeshkpour G.H., Dalakas M.C. Long-term changes in the spinal cords of patients with old poliomyelitis: signs of continuous disease activity. Arch Neurol 1988, 45:505-508.
334. Phillips C.A., Aronson M.D., Tomkow J., et al. Entero-viruses in Vermont 1969-1978: an important cause of illness throughout the year. J Infect Dis 1980, 141:162-164.
335. Pichimair A., Reis E., Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
336. Picornaviridae Study Group (2012). Available online at: (accessed 26 November 2012). http://www.picornastudygroup.com/types/index.html.
337. Plum F. Sensory loss with poliomyelitis. Neurology 1956, 6:166-172.
338. Plum F., Swanson A.G. Central neurogenic hyperventilation in man. Arch Neurol Psychiatry 1959, 81:531-549.
339. Ponka A., Petterson T. The incidence and aetio1ogy of central nervous system infections in Helsinki in 1980. Acta Neurol Scand 1982, 66:529-535.
340. Porter F.W., Bochkov Y.A., Albee A.J., et al. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc Natl Acad Sci U S A 2006, 103:12417-12422.
341. Price R.W., Plum F. Poliomyelitis. Handbook of clinical neurology, vol. 34. Infections of the nervous system, part II 1978, 93-132. North-Holland Publishing, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
342. Racaniello V.R. Picornaviridae: the viruses and their replication. Fields' virology 2007, 795-838. Lippincott Williams & Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
343. Racaniello V.R., Baltimore D. Molecular cloning of poliovirus eDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A 1981, 78:4887-4891.
344. Raney R.B., Brashear H.R., Shands A.R. Shands' handbook of orthopaedic surgery 1971, 180-185. C.V. Mosby, St. Louis.
345. Rao D.G., Bareman D.E. Hyperintensities of the anterior horn cells on MRI due to poliomyelitis. J Neurol Neurosurg Psychiatry 1997, 63:720.
346. Ren R., Racaniello V. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis 1992, 166:747-753.
347. Ren R.B., Moss E.G., Racaniello V.R. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 1991, 65:1377-1382.
348. Ren L., Gonzalez R., Xiao Y., et al. Saffold cardiovirus in children with acute gastroenteritis in Beijing, China. Emerg Infect Dis 2009, 15:1509-1511.
349. Ren L., Gonzalez R., Xie Z., et al. Saffold cardioviruses of 3 lineages in children with respiratory tract infections, Beijing, China. Emerg Infect Dis 2010, 16:1158-1161.
350. Richer M.J., Horwitz M.S. The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity. J Innate Immun 2009, 1:421-434.
351. Riker J.B., Brandt C.D., Chandra R., et al. Vaccine-associated poliomyelitis in a child with thymic abnormality. Pediatrics 1971, 48:923-929.
352. Rindge M.E. Poliomyelitis in pregnancy: a report of 79 cases in Connecticut. N Engl J Med 1957, 256:281-285.
353. Robbins F.C., Nightingale E.O. Selective primary health care: strategies for control of disease in the developing world. IX. Poliomyelitis. Rev Infect Dis 1983, 5:957-968.
354. Robbins F.C., Enders J.F., Weller T.H., et al. Studies on the cultivation of poliomyelitis viruses in tissue culture. V. The direct isolation and serologic identification of virus strains in tissue culture from patients with nonparalytic and paralytic poliomyelitis. Am J Hyg 1951, 54:286-293.
355. Robertson S.E., Traverso H.P., Drucker J.A., et al. Clinical efficacy of a new, enhanced potency, inactivated poliovirus vaccine. Lancet 1988, 1:897-899.
356. Rodden V.I., Cantor H.E., O'Connor D.M., et al. Acute hemiplegia of childhood associated with Coxsackie A9 viral infection. J Pediatr 1975, 86:56-58.
357. Roebuck M., Chamberlain R. Prevalence of antibodies to poliovirus in 1978 among subjects aged 0-88 years. Br Med J 1982, 284:697-700.
358. Rosen L., Melnick J.L., Schmidt N.J., et al. Subclassification of enteroviruses and echovirus type 34. Arch Gesamte Virusforsch 1970, 30:89-92.
359. Rossmann M.G., Arnold E., Erickson J.W., et al. Structure of a human common cold virus and functional relationship to other picornavirus. Nature 1985, 317:145-153.
360. Rousseau W.E., Noble G.R., Tegmeier G.E., et al. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine. N Engl J Med 1973, 289:1357-1359.
361. Rueckert R.R. On the structure and morphogenesis of picomaviruses. Comprehensive virology 1976, Vol. 6:131-213. Plenum, New York.
362. Rueckert R.R. Picornaviruses and their replication. Virology 1985, 705-738. Raven Press, New York. B.N. Fields, D.M. Knipe, R.M. Charnock (Eds.).
363. Rueckert R.R., Wimmer E. Systematic nomenclature of picornavirus proteins. J Virol 1984, 50:957-959.
364. Russell W.R. Paralytic poliomyelitis - the early symptoms and the effect of physical activity on the course of the disease. Br Med J 1949, 1:465-471.
365. Sabin A.B. Transitory appearance of type 2 neutralizing antibody in patients infected with type I poliomyelitis virus. J Exp Med 1952, 96:99-106.
366. Sabin A.B. Pathogenesis of poliomyelitis. Reappraisal in the light of new data. Science 1956, 123:1151-1157.
367. Sabin A.B. Properties of attenuated polioviruses and their behavior in human beings. Cellular biology, nucleic acids and viruses 1957, 113-127. New York Academy of Sciences, New York. O.V. St. Whitelock (Ed.).
368. Sabin A.B. Oral poliovirus vaccine: history of its developments and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 1985, 151:420-436.
369. Sabin A.B., Krumbiegel E.R., Wigand R. ECHO type 9 virus disease. Am J Dis Child 1958, 96:197-219.
370. Sabin A.B., Michaels R.H., Krugman S., et al. Effect of oral poliovaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth. Pediatrics 1963, 31:641-650.
371. Salit J.E. Sporadic postinfectious neuromyasthenia. Can Med Assoc J 1985, 133:659-663.
372. Salk J.E. Considerations in the preparation and use of poliomyelitis virus vaccine. JAMA 1955, 158:1239-1248.
373. Salk D. Eradication of poliomyelitis in the United States. III. Practical considerations. Rev Infect Dis 1980, 2:258-273.
374. Schmidt J.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129:304-309.
375. Sells C.J., Carpenter R.L., Ray C.G. Sequelae of central nervous system enterovirus infections. N Engl J Med 1975, 293:1-4.
376. Shafren D.R., Dorahy D.J., Ingham R.H., et al. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 1997, 71:4736-4743.
377. Shen W.-C., Chiu H.-H., Chow K.-C., et al. MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol 1999, 20:1889-1895.
378. Sherry B., Mosser A.G., Colonno R.J., et al. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 1986, 57:246-257.
379. Simons J., Kutubuddin M., Chow M. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of vaccinated humans. J Virol 1992, 67:1262-1268.
380. Singer J.I., Maur P.R., Riley I.P., et al. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 1980, 96:559-563.
381. Spear P.G. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004, 6:401-410.
382. Stanway G., Hyypia T. Parechoviruses. J Virol 1999, 73:5249-5254.
383. Stanway G., Cann A.J., Hauptmann R., et al. The nucleotide sequence of poliovirus type 3 Leon 12 A, 43B: Comparison with poliovirus type 3. Nucl Acids Res 1983, 11:5629-5643.
384. Stanway G., Hughes P.J., Mountford R.C., et al. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leonf37 and its attenuated Sabin vaccine derivation P3/Leon 12a, b. Proc Natl Acad Sci U S A 1984, 81:1539-1543.
385. Stanway G., Brown F., Christian P., et al. Family Picornaviridae. Virus taxonomy, Eighth Report of the International Committee on the Taxonomy of Viruses 2005, 757-778. Elsevier Academic Press, London. C.M. Fauquet, M.A. Mayo, J. Maniloff (Eds.).
386. Staunton D.E., Merluzzi V.J., Rothlein R., et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989, 56:849-853.
387. Stevens K.M. Estimate of molecular equivalent of antibody required for prophylaxis and therapy of poliomyelitis. J Hyg 1959, 57:198-200.
388. Strauss S.E. The chronic mononucleosis syndrome. J Infect Dis 1988, 157:405-412.
389. Svehag S.E., Mandel B. The formation and properties of poliovirus-neutralizing antibody of rabbit origin. I. 19S and 7S antibody formation difference in kinetics and antigen dose requirement for induction. J Exp Med 1964, 119:1-19.
390. Tam P.E., Weber-Sanders M.L., Messner R.P. Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 2003, 77:11849-11854.
391. Tang T.T., Sedmak G.V., Siegesmund K.A., et al. Chronic myopathy associated with coxsackie virus type A9. N Engl J Med 1975, 292:608-611.
392. Tatem J.M., Weeks-Levy C., Georgiu A., et al. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol 1992, 66:3194-3197.
393. Tesh R.B. The prevalence of encephalomyocarditis virus neutralizing antibodies among various human populations. Am J Trop Med Hyg 1978, 27:144-149.
394. Tesh R.B., Wallace G.D. Observations on the natural history of encephalomyocarditis virus. Am J Trop Med Hyg 1978, 27:133-143.
395. Theiler M. Spontaneous encephalomyelitis of mice - a new virus disease. Science 1934, 80:122.
396. Thivierge B., Delage G. Infections du systèmes nerveux central à entrovirus: 233 cas vus a un hÔpital pédiatrique entre 1973 et 1981. Can Med Assoc J 1982, 127:1097-1102.
397. Thomas J.E., Howard F.M. Segmental zoster paresis, a disease profile. Neurology 1972, 22:459-466.
398. Tomassini J.E., Graham D., Dewitt C.M., et al. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1989, 86:4907-4911.
399. Toyoda H., Kohara M., Karaoka Y., et al. Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol 1984, 174:561-585.
400. Trask J.D., Vignec A.J., Paul J.R. Poliomyelitis virus in human stools. JAMA 1938, 111:6-11.
401. Travers R.L., Hughes G.R.V., Cambridge G., et al. Coxsackie B neutralization titres in polymyositis/dermatomyositis. Lancet 1977, I:1268.
402. Triantafilou K., Triantafilou M., Takada Y., et al. Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors. J Virol 2000, 74:5856-5862.
403. Trimble G.X. Epidemic neuromyasthenia. N Engl J Med 1969, 281:105-106.
404. Vallet S., Legrand-Quillien M.-C., Dailland T., et al. Fatal case of enterovirus 71 infection, France, 2007. Emerg Infect Dis 2009, 15:1837-1840.
405. Van Eden W., Persijn G.G., Bijkerk H., et al. Differential resistance to paralytic poliomyelitis controlled by histocompatibility leukocyte antigens. J Infect Dis 1983, 147:422-426.
406. Varki A.P., Puthuran P. Value of second lumbar puncture in confirming a diagnosis of aseptic meningitis, a prospective study. Arch Neurol 1979, 36:581-582.
407. Vejajiva A. Acute hemorrhagic conjunctivitis with neurologic complications. Handbook of clinical neurology, viral disease 1989, 349-354. Elsevier North-Holland, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
408. Vogel E. Recognition, treatment and control of poliomyelitis. Med Prog 1950, 242:899-908.
409. Von Herrath M.G., Holz A., Homann D., et al. Role of viruses in type 1 diabetes. Semin Immunol 1998, 10:87-100.
410. Wadia N.H., Irani P.F., Katrak S.M. Neurological complications of a new conjunctivitis. Lancet 1972, 2:970-971.
411. Wadia N.H., Katrak S.M., Misra V.P., et al. Polio-like motor paralysis associated with acute hemorrhagic conjunctivitis in an outbreak in 1981 in Bombay, India: Clinical and serologic studies. J Infect Dis 1983, 147:660-668.
412. Walker J.E., Cook J.D. Lymphoblastic transformation in response to viral antigens in multiple sclerosis. Neurology 1979, 29:1341-1347.
413. Walters J.H. Postencephalitic Parkinson syndrome after meningoencephalitis due to Coxsackievirus group B, type 2. N Engl J Med 1960, 263:744-747.
414. Wang K., Sun L., Jubelt B., et al. Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responses. Cell Immunol 1990, 119:252-262.
415. Wang J.P., Cerny A., Asher D.R., et al. MDA5 and MAVS mediate type I interferon responses to Coxsackie B virus. J Virol 2010, 84:254-260.
416. Webster A.D.B., Tripp J.H., Hayward A.R., et al. Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child 1978, 53:33-37.
417. Weiner L.P. Enterovirus infections of the nervous system other than poliovirus. Handbook of Clinical Neurology, vol. 34. Infections of the nervous system, part II 1978, 133-143. North Holland Publishing, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
418. Weiner L.S., Howell J.T., Langford M.P., et al. Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis 1979, 140:858-863.
419. Weinstein L. Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. N Engl J Med 1957, 257:47-52.
420. Welliver R.C., Drucker M.M., Ogra P.L. Immunology of enteroviruses. Comprehensive immunology 1982, Vol. 9:185-203. Plenum, New York. A.J. Nahmias, R.J. O'Reilly (Eds.).
421. Wenner H.A. The enteroviruses: recent advances. Yale J Biol Med 1982, 55:277-282.
422. Wenner H.A., Kamitsuka P. Further observations on the widespread distribution of poliomyelitis virus on body tissues following intramuscular inoculation of cynomolgus monkeys. Virology 1956, 2:83-95.
423. Wenner H.A., Miller C.A., Kamitsuka P., et al. Preparation and standardization of antiserums prepared with the three known types of poliomyelitis viruses. Am J Hyg 1954, 59:221-235.
424. Wenner H.A., Kamitsuka P., Lenahan M., et al. The pathogenesis of poliomyelitis, site of multiplication of poliovirus in cynomolgus monkeys after alimentary infection. Arch Gesamte Virusforsch 1959, 9:537-558.
425. Westrop G.D., Wareham K.A., Evans D.M., et al. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 1989, 63:1338-1344.
426. Wickman L. Beitrage zur Kenntnis der Heine Medinschen Krankheit (Poliomyelitis acuta und verwandter Erkrankungen) 1907, Karger, Berlin.
427. Wilfert C.M., Buckley R.H., Mohanakumar T., et al. Persistent and fatal central nervous system ECHO virus infections in patients with agammaglobulinemia. N Engl J Med 1977, 296:1485-1489.
428. Wilfert C.M., Thompson R.J., Sunder T.R., et al. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics 1981, 67:811-815.
429. Wolinsky J.S., Jubelt B., Burke S., et al. Hematogenous origin of the inflammatory response in acute poliomyelitis. Ann Neurol 1982, 11:59-68.
430. Wong C.Y., Woodruff J.J., Woodruff J.R. Generation of cytotoxic lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity. J lmmunol 1977, 118:1159-1164.
431. Wong C.Y., Woodruff J.J., Woodruff J.R. Generation of cytotoxic T lymphocytes during coxsackievirus B 3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myofibers. J lmmunol 1977, 118:1165-1169.
432. Wong S.S.Y., Ypi C.C.Y., Lau S.K.P., et al. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 2010, 138:1071-1089.
433. Wright P.F., Hatch M.H., Kasselberg A.G., et al. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr 1977, 91:408-412.
434. Wyatt H.V. Poliomyelitis in hypogammaglobulinemics. J Infect Dis 1973, 12:802-806.
435. Yamayoshi S., Yamashita Y., Li J., et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009, 15:30-41.
436. Yang T.T., Huang L.M., Lu C.Y., et al. Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994-2003. J Microbiol Immunol Infect 2005, 38:417-424.
437. Yin Murphy M. Acute hemorrhagic conjunctivitis. Prog Med Virol 1984, 29:23-44.
438. Yodfat Y., Nishmi M. Epidemiologic and clinical observations in six outbreaks of viral disease in a kibbutz. Am J Epidemiol 1973, 97:415-423.
439. Young N.A. Polioviruses, coxsackieviruses, and echoviruses: comparison of genomes by RNA hybridization. J Virol 1973, 11:832-839.
440. Yousef G.E., Bell E.J., Mann G.F., et al. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988, 1:146-150.
441. Yunus M., Masi A.T., Calabro J.J., et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981, 11:151-171.
442. Zoll J., Hulshof S.E., Lanke K., et al. Saffold virus, a new human Theiler's like cardiovirus, is ubiquitious and causes infection early in life. PLoS Pathog 2009, 5:1-10.